JP2012511895A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012511895A5 JP2012511895A5 JP2011536563A JP2011536563A JP2012511895A5 JP 2012511895 A5 JP2012511895 A5 JP 2012511895A5 JP 2011536563 A JP2011536563 A JP 2011536563A JP 2011536563 A JP2011536563 A JP 2011536563A JP 2012511895 A5 JP2012511895 A5 JP 2012511895A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- diseases
- brain
- neurological
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000010099 disease Diseases 0.000 description 7
- 230000002068 genetic Effects 0.000 description 4
- 210000004556 Brain Anatomy 0.000 description 3
- 208000009025 Nervous System Disease Diseases 0.000 description 3
- 206010029305 Neurological disorder Diseases 0.000 description 3
- 230000003542 behavioural Effects 0.000 description 3
- 230000000926 neurological Effects 0.000 description 3
- 102100007712 TSPOAP1 Human genes 0.000 description 2
- 101710041459 TSPOAP1 Proteins 0.000 description 2
- 206010001897 Alzheimer's disease Diseases 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- 210000004204 Blood Vessels Anatomy 0.000 description 1
- 208000008581 Brain Disease Diseases 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 210000000349 Chromosomes Anatomy 0.000 description 1
- 206010015037 Epilepsy Diseases 0.000 description 1
- 201000001971 Huntington's disease Diseases 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- 206010027175 Memory impairment Diseases 0.000 description 1
- 108020004999 Messenger RNA Proteins 0.000 description 1
- 208000003627 Muscular Dystrophy Diseases 0.000 description 1
- 206010053643 Neurodegenerative disease Diseases 0.000 description 1
- 229920000272 Oligonucleotide Polymers 0.000 description 1
- 206010061536 Parkinson's disease Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 210000000278 Spinal Cord Anatomy 0.000 description 1
- 208000006097 Spinal Dysraphism Diseases 0.000 description 1
- 206010061367 Spinal cord disease Diseases 0.000 description 1
- 210000003802 Sputum Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001430 anti-depressive Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000001149 cognitive Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 231100000870 cognitive problem Toxicity 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- 201000009906 meningitis Diseases 0.000 description 1
- 230000003340 mental Effects 0.000 description 1
- 229920002106 messenger RNA Polymers 0.000 description 1
- 230000000051 modifying Effects 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002569 neurons Anatomy 0.000 description 1
- 230000002093 peripheral Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 201000010829 spina bifida Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000152 swallowing Effects 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
Description
【0005】
神経疾患は、脳、脊髄、及び神経の疾患に起因することがある。神経疾患患者は、行動、言語、嚥下、呼吸または学習トラブルを有することがある。記憶障害、行動または心的認識の問題もまた、神経疾患に関連している。神経機能障害には様々な根本的な原因がある。これらには、遺伝的変異、有害物質への曝露及び障害を含めることができる。
神経疾患は600種以上存在する。主なタイプは、ハンチントン病及び筋ジストロフィーのような遺伝子欠損により引き起こされる疾患;二分脊椎のような神経系の異常胚発達;パーキンソン病及びアルツハイマー病のような神経細胞が損傷または死んでいる変性疾患、脳卒中のような脳に血液を供給する血管の疾患;脊髄及び脳への傷害;癲癇のような発作障害;脳腫瘍のような癌;髄膜炎のような感染症を含む。
ヒトの認知及び行動の複数の疾患は、遺伝的要因により変調するように思われる。しかしながら、遺伝的変異の影響する疾患の様式は複雑であり、よくわかっていない。同様にとらえどころのないことして、診断及び治療介入に関して有用な特定の遺伝子の正体が挙げられる。本発明の目的はこれらの遺伝子マーカーを提供すること及びさらには認知機能及び神経発達の損失につながる変化を特徴づけることである。
この出願の発明に関連する先行技術文献情報としては、以下のものがある(国際出願日以降国際段階で引用された文献及び他国に国内移行した際に引用された文献を含む)。
【先行技術文献】
【特許文献】
神経疾患は、脳、脊髄、及び神経の疾患に起因することがある。神経疾患患者は、行動、言語、嚥下、呼吸または学習トラブルを有することがある。記憶障害、行動または心的認識の問題もまた、神経疾患に関連している。神経機能障害には様々な根本的な原因がある。これらには、遺伝的変異、有害物質への曝露及び障害を含めることができる。
神経疾患は600種以上存在する。主なタイプは、ハンチントン病及び筋ジストロフィーのような遺伝子欠損により引き起こされる疾患;二分脊椎のような神経系の異常胚発達;パーキンソン病及びアルツハイマー病のような神経細胞が損傷または死んでいる変性疾患、脳卒中のような脳に血液を供給する血管の疾患;脊髄及び脳への傷害;癲癇のような発作障害;脳腫瘍のような癌;髄膜炎のような感染症を含む。
ヒトの認知及び行動の複数の疾患は、遺伝的要因により変調するように思われる。しかしながら、遺伝的変異の影響する疾患の様式は複雑であり、よくわかっていない。同様にとらえどころのないことして、診断及び治療介入に関して有用な特定の遺伝子の正体が挙げられる。本発明の目的はこれらの遺伝子マーカーを提供すること及びさらには認知機能及び神経発達の損失につながる変化を特徴づけることである。
この出願の発明に関連する先行技術文献情報としては、以下のものがある(国際出願日以降国際段階で引用された文献及び他国に国内移行した際に引用された文献を含む)。
【先行技術文献】
【特許文献】
【0006】
【特許文献1】 米国特許出願公開第2005/10209181号明細書
【特許文献2】 米国特許出願公開第2006/0051786号明細書
【非特許文献】
【特許文献1】 米国特許出願公開第2005/10209181号明細書
【特許文献2】 米国特許出願公開第2006/0051786号明細書
【非特許文献】
【0007】
【非特許文献1】 SEO et al. An accurate method for quantifying and analyzing copy number variation in porcine KIT by an oligonucleotide ligation assay. BMC Genet. 2007, 8(Artlcle 81):1−11; Abstract.
【非特許文献2】 MARSHALL et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. February 2008, 82(2):477−488.
【非特許文献3】 KUOKKANEN et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am. J. Hum. Genet. December 1997, 61(6):1379−1387.
【非特許文献4】 CHARDENOT et al. Expression profile and up−regUlation of PRAX−1 mRNA by antidepressant treatment in the rat brain. Mol. Pharmacol. 2002, 62(6):1314−1320.
【非特許文献5】 GALLIEGUE et al. Cloning and characterization of PRAX−1. A new protein that specifically interacts with the peripheral benzodlazepine receptor. J. Bioi. Chem. 1999,274(5):2938−2952.
【非特許文献6】 BUCAN et al. Genome−wide analyses of exonlc copy number variants In a family−based study point to novel autism susceptibility genes. PLoS Genet. June 2009, 5(6):article e1000536, pages 1−12.
【発明の概要】
【課題を解決するための手段】
【非特許文献1】 SEO et al. An accurate method for quantifying and analyzing copy number variation in porcine KIT by an oligonucleotide ligation assay. BMC Genet. 2007, 8(Artlcle 81):1−11; Abstract.
【非特許文献2】 MARSHALL et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. February 2008, 82(2):477−488.
【非特許文献3】 KUOKKANEN et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am. J. Hum. Genet. December 1997, 61(6):1379−1387.
【非特許文献4】 CHARDENOT et al. Expression profile and up−regUlation of PRAX−1 mRNA by antidepressant treatment in the rat brain. Mol. Pharmacol. 2002, 62(6):1314−1320.
【非特許文献5】 GALLIEGUE et al. Cloning and characterization of PRAX−1. A new protein that specifically interacts with the peripheral benzodlazepine receptor. J. Bioi. Chem. 1999,274(5):2938−2952.
【非特許文献6】 BUCAN et al. Genome−wide analyses of exonlc copy number variants In a family−based study point to novel autism susceptibility genes. PLoS Genet. June 2009, 5(6):article e1000536, pages 1−12.
【発明の概要】
【課題を解決するための手段】
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11492108P | 2008-11-14 | 2008-11-14 | |
US61/114,921 | 2008-11-14 | ||
PCT/US2009/064617 WO2010057112A2 (en) | 2008-11-14 | 2009-11-16 | Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012511895A JP2012511895A (ja) | 2012-05-31 |
JP2012511895A5 true JP2012511895A5 (ja) | 2013-01-17 |
Family
ID=42170776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011536563A Pending JP2012511895A (ja) | 2008-11-14 | 2009-11-16 | ヒト認知の原因となる遺伝子変異体及び診断標的及び治療標的としてのそれらを使用する方法 |
Country Status (6)
Country | Link |
---|---|
US (3) | US20110311512A1 (ja) |
EP (1) | EP2376655B1 (ja) |
JP (1) | JP2012511895A (ja) |
AU (1) | AU2009313759B2 (ja) |
CA (1) | CA2766246C (ja) |
WO (1) | WO2010057112A2 (ja) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10522240B2 (en) | 2006-05-03 | 2019-12-31 | Population Bio, Inc. | Evaluating genetic disorders |
US7702468B2 (en) | 2006-05-03 | 2010-04-20 | Population Diagnostics, Inc. | Evaluating genetic disorders |
JP5881420B2 (ja) * | 2008-11-12 | 2016-03-09 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション | 自閉症関連遺伝子マーカー |
JP5728813B2 (ja) * | 2010-02-25 | 2015-06-03 | 国立大学法人三重大学 | 冠動脈疾患の遺伝的リスク検出法 |
US8862410B2 (en) | 2010-08-02 | 2014-10-14 | Population Diagnostics, Inc. | Compositions and methods for discovery of causative mutations in genetic disorders |
AU2011293363A1 (en) * | 2010-08-24 | 2013-02-28 | The Children's Hospital Of Philadelphia | Association of rare recurrent genetic variations to attention-deficit, hyperactivity disorder (ADHD) and methods of use thereof for the diagnosis and treatment of the same |
WO2013006857A1 (en) * | 2011-07-07 | 2013-01-10 | The Children's Hospital Of Philadelphia | Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatment of autism |
WO2016022324A1 (en) * | 2014-05-30 | 2016-02-11 | The Children's Hospital Of Philadelphia | Genetic alterations associated with autism and autistic phenotype and methods of diagnosing and treating autism |
WO2013054200A2 (en) | 2011-10-10 | 2013-04-18 | The Hospital For Sick Children | Methods and compositions for screening and treating developmental disorders |
US11180807B2 (en) | 2011-11-04 | 2021-11-23 | Population Bio, Inc. | Methods for detecting a genetic variation in attractin-like 1 (ATRNL1) gene in subject with Parkinson's disease |
CA2863887C (en) | 2012-02-09 | 2023-01-03 | Population Diagnostics, Inc. | Methods of screening low frequency gdna variation biomarkers for pervasive developmental disorder (pdd) or pervasive developmental disorder - not otherwise specified (pdd_nos) |
US9714450B2 (en) | 2012-08-31 | 2017-07-25 | New York University | Methods for diagnosing and treating schizophrenia |
DK2895621T3 (da) | 2012-09-14 | 2020-11-30 | Population Bio Inc | Fremgangsmåder og sammensætning til diagnosticering, prognose og behandling af neurologiske tilstande |
EP2900835A4 (en) | 2012-09-27 | 2016-05-11 | Population Diagnotics Inc | METHODS AND COMPOSITIONS FOR DETECTING AND TREATING DEVELOPMENTAL DISORDERS |
EP2904117A4 (en) * | 2012-10-04 | 2016-11-09 | Lineagen Inc | ASSOCIATED GENETIC MARKERS ASSOCIATED WITH ASD AND OTHER CHILDHOOD DEVELOPMENT DISORDERS |
WO2014121180A1 (en) * | 2013-02-01 | 2014-08-07 | The University Of Chicago | Genetic variants in interstitial lung disease subjects |
WO2014152965A2 (en) * | 2013-03-14 | 2014-09-25 | The Children's Hospital Of Philadelphia | Schizophrenia-associated genetic loci identified in genome wide association studies and use thereof as novel therapeutic targets |
JP6104058B2 (ja) * | 2013-06-03 | 2017-03-29 | 花王株式会社 | カビ臭抑制剤の探索方法 |
US11219617B2 (en) | 2014-05-30 | 2022-01-11 | The Children's Hospital Of Philadelphia | Methods of diagnosing and treating autism |
GB2558326B (en) | 2014-09-05 | 2021-01-20 | Population Bio Inc | Methods and compositions for inhibiting and treating neurological conditions |
EP3347016B1 (en) | 2015-09-08 | 2021-04-28 | The Children's Hospital of Philadelphia | Diagnosing and treating anxiety disorder |
US10240205B2 (en) | 2017-02-03 | 2019-03-26 | Population Bio, Inc. | Methods for assessing risk of developing a viral disease using a genetic test |
JP6942036B2 (ja) * | 2017-11-30 | 2021-09-29 | 藤倉化成株式会社 | 脳梗塞の発症リスクを高感度に検出する体液抗体バイオマーカー |
CA3108807A1 (en) | 2018-08-08 | 2020-02-13 | Pml Screening, Llc | Methods for assessing the risk of developing progressive multifocal leukoencephalopathy caused by john cunningham virus by genetic testing |
KR102250063B1 (ko) * | 2019-06-14 | 2021-05-12 | 한국생명공학연구원 | 뚜렛증후군의 원인 유전자를 동정하는 방법 |
KR102189144B1 (ko) * | 2020-10-15 | 2020-12-09 | 서울대학교병원 | 만성신장질환 악화 예측 마커 및 이를 이용한 악화 예측 방법 |
US20220403469A1 (en) * | 2021-06-17 | 2022-12-22 | United States Government As Represented By The Department Of Veterans Affairs | Precision Medicine for Schizophrenia and Psychotic Disorders: Objective Assessment, Risk Prediction, Pharmacogenomics, and Repurposed Drugs |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
US7670767B1 (en) * | 1997-01-16 | 2010-03-02 | The Regents Of The University Of California | Genetic alterations associated with cancer |
US20050209181A1 (en) * | 2003-11-05 | 2005-09-22 | Huda Akil | Compositions and methods for diagnosing and treating mental disorders |
EP1766077B1 (en) * | 2004-06-21 | 2012-03-28 | The Board Of Trustees Of The Leland Stanford Junior University | Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder |
-
2009
- 2009-11-16 WO PCT/US2009/064617 patent/WO2010057112A2/en active Application Filing
- 2009-11-16 CA CA2766246A patent/CA2766246C/en active Active
- 2009-11-16 AU AU2009313759A patent/AU2009313759B2/en not_active Ceased
- 2009-11-16 JP JP2011536563A patent/JP2012511895A/ja active Pending
- 2009-11-16 US US13/129,526 patent/US20110311512A1/en not_active Abandoned
- 2009-11-16 EP EP09826923.6A patent/EP2376655B1/en active Active
-
2014
- 2014-09-29 US US14/501,006 patent/US20150051114A1/en not_active Abandoned
-
2018
- 2018-03-12 US US15/918,755 patent/US20180274032A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2012511895A5 (ja) | ||
Lee et al. | De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal neuropathy, and cerebellar atrophy | |
Urano | Wolfram syndrome: diagnosis, management, and treatment | |
Züchner et al. | Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies | |
Valdmanis et al. | Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p | |
Workman et al. | Rapid antidepressants stimulate the decoupling of GABAB receptors from GIRK/Kir3 channels through increased protein stability of 14-3-3η | |
Field et al. | Expanding the molecular basis and phenotypic spectrum of X-linked Joubert syndrome associated with OFD1 mutations | |
Darvesh et al. | Reduced fibrillar β-amyloid in subcortical structures in a butyrylcholinesterase-knockout Alzheimer disease mouse model | |
Hirst et al. | Complicated spastic paraplegia in patients with AP5Z1 mutations (SPG48) | |
JP7105256B2 (ja) | 伸長ヌクレオチド反復を含有する遺伝子の有害活性の低減のための化合物 | |
Vainshtein et al. | Quinazoline-based tricyclic compounds that regulate programmed cell death, induce neuronal differentiation, and are curative in animal models for excitotoxicity and hereditary brain disease | |
Suh | A new era of disease modeling and drug discovery using induced pluripotent stem cells | |
Wang et al. | The relationship of olfactory function and clinical traits in major depressive disorder | |
Wilson et al. | Effects of optogenetic stimulation of basal forebrain parvalbumin neurons on Alzheimer’s disease pathology | |
Miller et al. | Novel inter-hemispheric white matter connectivity in the BTBR mouse model of autism | |
Kumari et al. | U1 snRNA over-expression affects neural oscillations and short-term memory deficits in mice | |
Khan et al. | PDCD6IP, encoding a regulator of the ESCRT complex, is mutated in microcephaly | |
WO2006091964A8 (en) | Regulators of protein misfolding and aggregation and methods of using the same | |
Jiao et al. | TMEM106B aggregation in neurodegenerative diseases: linking genetics to function | |
CN105246475A (zh) | 用于治疗dna修复缺陷障碍的治疗剂和方法 | |
Balendra et al. | Quo vadis motor neuron disease? | |
Renton | An update on pain. | |
AU2018376605B2 (en) | A novel method of treating dystonia | |
US10882821B1 (en) | Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes | |
Cuturic | Huntington’s Disease |